Biolase (FRA:BTH0) Additional Paid-In Capital : €296.20 Mil(As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Biolase Additional Paid-In Capital?

Biolase's quarterly additional paid-in capital declined from Sep. 2023 (€292.83 Mil) to Dec. 2023 (€290.78 Mil) but then increased from Dec. 2023 (€290.78 Mil) to Mar. 2024 (€296.20 Mil).

Biolase's annual additional paid-in capital increased from Dec. 2021 (€259.59 Mil) to Dec. 2022 (€284.89 Mil) and increased from Dec. 2022 (€284.89 Mil) to Dec. 2023 (€290.78 Mil).

Biolase Additional Paid-In Capital Historical Data

The historical data trend for Biolase's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolase Additional Paid-In Capital Chart

Biolase Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

212.04

215.01

259.59

284.89

290.78

Biolase Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															290.29	289.93	292.83	290.78	296.20

Biolase Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Biolase Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Biolase's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolase (FRA:BTH0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolase Inc (FRA:BTH0) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

BIOL:USA BTH0:Germany

Address

27042 Towne Centre Drive, Suite 270, Lake Forest, CA, USA, 92610

Website

https://www.biolase.com

Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.

Biolase (FRA:BTH0) Headlines

No Headlines